ERBB2 and infection: These recommendations included (1) using antiemetics to avoid acute or delayed emesis induced by chemotherapy [37]; (2) applying measures to prevent surgical infections [46]; (3) using primary prophylaxis with granulocyte colony-stimulating factors in patients receiving chemotherapy [27]; (4) monitoring left ventricular ejection fraction (LVEF) during anti-HER2 therapy [76], and (5) indicating vitamin D and calcium in patients receiving adjuvant non-steroidal aromatase inhibitors [75].